WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009610) USE OF NUCLEOSIDE COMPOUNDS FOR NONSENSE SUPPRESSION AND THE TREATMENT OF GENETIC DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009610    International Application No.:    PCT/US2003/023185
Publication Date: 29.01.2004 International Filing Date: 23.07.2003
Chapter 2 Demand Filed:    19.02.2004    
IPC:
C07H 19/00 (2006.01)
Applicants: PTC THERAPEUTICS, INC. [US/US]; 100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080 (US) (For All Designated States Except US).
TULARIK INC. [US/US]; 1120 Veterans Boulevard, South San Francisco, CA 94080 (US) (For All Designated States Except US).
WILDE, Richard, G. [US/US]; (US) (For US Only).
ALMSTEAD, Neil, G. [US/US]; (US) (For US Only).
WELCH, Ellen, M. [US/US]; (US) (For US Only).
BECKMANN, Holger [DE/DE]; (DE) (For US Only)
Inventors: WILDE, Richard, G.; (US).
ALMSTEAD, Neil, G.; (US).
WELCH, Ellen, M.; (US).
BECKMANN, Holger; (DE)
Agent: INSOGNA, Anthony, M.; Jones Day LLP, 222 East 41st Street, New York, NY 10017 (US)
Priority Data:
60/398,334 24.07.2002 US
Title (EN) USE OF NUCLEOSIDE COMPOUNDS FOR NONSENSE SUPPRESSION AND THE TREATMENT OF GENETIC DISEASES
(FR) UTILISATION DE COMPOSES NUCLEOSIDIQUES POUR LA SUPPRESSION NON-SENS ET LE TRAITEMENT DE MALADIES GENETIQUES
Abstract: front page image
(EN)The invention encompasses nucleoside compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.
(FR)L'invention concerne des composé nucléosidiques, des compositions contenant les composés et des méthodes de traitement ou de prévention de maladies associées à des mutations non-sens d'ARNm par administration de ces composés ou compositions.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)